CN102872286A - 一种治疗腰间盘突出的中药组合物及其制备方法 - Google Patents
一种治疗腰间盘突出的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN102872286A CN102872286A CN2012102994239A CN201210299423A CN102872286A CN 102872286 A CN102872286 A CN 102872286A CN 2012102994239 A CN2012102994239 A CN 2012102994239A CN 201210299423 A CN201210299423 A CN 201210299423A CN 102872286 A CN102872286 A CN 102872286A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- blood
- medicine
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 159
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims description 43
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 claims abstract description 51
- 241000218176 Corydalis Species 0.000 claims abstract description 18
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 11
- 241001446509 Psoralea Species 0.000 claims abstract description 7
- 229940079593 drug Drugs 0.000 claims description 51
- 208000012287 Prolapse Diseases 0.000 claims description 48
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- 241001489978 Eupolyphaga Species 0.000 claims description 26
- 241000628997 Flos Species 0.000 claims description 19
- 239000000463 material Substances 0.000 claims description 19
- 238000010438 heat treatment Methods 0.000 claims description 18
- 239000011505 plaster Substances 0.000 claims description 18
- 210000000582 semen Anatomy 0.000 claims description 18
- 238000000605 extraction Methods 0.000 claims description 17
- 239000009286 sanguis draxonis Substances 0.000 claims description 17
- 241000208152 Geranium Species 0.000 claims description 16
- 241000522620 Scorpio Species 0.000 claims description 16
- 241000717739 Boswellia sacra Species 0.000 claims description 15
- 239000004863 Frankincense Substances 0.000 claims description 15
- 241001264480 Lycopodiastrum casuarinoides Species 0.000 claims description 15
- 239000006187 pill Substances 0.000 claims description 15
- 239000009490 scorpio Substances 0.000 claims description 15
- 241000903946 Clematidis Species 0.000 claims description 14
- 241001057584 Myrrha Species 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 14
- 239000002552 dosage form Substances 0.000 claims description 12
- 238000007670 refining Methods 0.000 claims description 12
- 239000011347 resin Substances 0.000 claims description 12
- 229920005989 resin Polymers 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 12
- 230000003203 everyday effect Effects 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 11
- 238000000108 ultra-filtration Methods 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 8
- 238000010828 elution Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 230000006837 decompression Effects 0.000 claims description 7
- 238000004064 recycling Methods 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 241000545442 Radix Species 0.000 claims description 6
- 241001180876 Saposhnikovia Species 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 6
- 238000004821 distillation Methods 0.000 claims description 6
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims description 6
- 239000002674 ointment Substances 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 5
- -1 sublimed preparation Substances 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 239000003053 toxin Substances 0.000 claims description 5
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 230000000274 adsorptive effect Effects 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 229920000742 Cotton Polymers 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 239000000571 coke Substances 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 239000003129 oil well Substances 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 239000008298 dragée Substances 0.000 claims description 2
- 238000002481 ethanol extraction Methods 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 238000003958 fumigation Methods 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 230000008719 thickening Effects 0.000 claims description 2
- 229940098465 tincture Drugs 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 144
- 210000004369 blood Anatomy 0.000 abstract description 137
- 208000002193 Pain Diseases 0.000 abstract description 88
- 230000036407 pain Effects 0.000 abstract description 85
- 210000003734 kidney Anatomy 0.000 abstract description 56
- 230000000694 effects Effects 0.000 abstract description 40
- 230000017531 blood circulation Effects 0.000 abstract description 26
- 230000001737 promoting effect Effects 0.000 abstract description 24
- 238000005728 strengthening Methods 0.000 abstract description 14
- 230000001717 pathogenic effect Effects 0.000 abstract description 12
- 230000000638 stimulation Effects 0.000 abstract description 11
- 230000003014 reinforcing effect Effects 0.000 abstract description 3
- 241000427159 Achyranthes Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001254604 Angelica pubescens Species 0.000 abstract 1
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 241000234276 Curculigo Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241001116742 Drynaria Species 0.000 abstract 1
- 235000009967 Erodium cicutarium Nutrition 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 235000014066 European mistletoe Nutrition 0.000 abstract 1
- 241001504070 Huperzia Species 0.000 abstract 1
- 241000244365 Ligusticum sinense Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 244000152640 Rhipsalis cassutha Species 0.000 abstract 1
- 235000012300 Rhipsalis cassutha Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 39
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 39
- 210000001624 hip Anatomy 0.000 description 37
- 210000003205 muscle Anatomy 0.000 description 36
- 208000008035 Back Pain Diseases 0.000 description 35
- 241000283973 Oryctolagus cuniculus Species 0.000 description 34
- 208000008930 Low Back Pain Diseases 0.000 description 33
- 210000004185 liver Anatomy 0.000 description 30
- 238000000034 method Methods 0.000 description 26
- 238000012360 testing method Methods 0.000 description 26
- 210000000988 bone and bone Anatomy 0.000 description 25
- 208000006820 Arthralgia Diseases 0.000 description 22
- 230000007812 deficiency Effects 0.000 description 20
- 210000005036 nerve Anatomy 0.000 description 20
- 208000014674 injury Diseases 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 15
- 210000001015 abdomen Anatomy 0.000 description 15
- 241000700199 Cavia porcellus Species 0.000 description 14
- 208000027418 Wounds and injury Diseases 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 14
- 230000006870 function Effects 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 13
- 230000000202 analgesic effect Effects 0.000 description 12
- 210000003414 extremity Anatomy 0.000 description 12
- 239000007789 gas Substances 0.000 description 12
- 210000003141 lower extremity Anatomy 0.000 description 12
- 229940023488 pill Drugs 0.000 description 12
- 201000000736 Amenorrhea Diseases 0.000 description 11
- 206010001928 Amenorrhoea Diseases 0.000 description 11
- 206010052428 Wound Diseases 0.000 description 11
- 231100000540 amenorrhea Toxicity 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 10
- 206010030113 Oedema Diseases 0.000 description 10
- 230000008901 benefit Effects 0.000 description 10
- 238000002560 therapeutic procedure Methods 0.000 description 10
- 230000008736 traumatic injury Effects 0.000 description 10
- 206010019233 Headaches Diseases 0.000 description 9
- 231100000869 headache Toxicity 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 210000003462 vein Anatomy 0.000 description 9
- 239000009157 yaotongning Substances 0.000 description 9
- 206010013935 Dysmenorrhoea Diseases 0.000 description 8
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- 230000003110 anti-inflammatory effect Effects 0.000 description 8
- 210000001367 artery Anatomy 0.000 description 8
- 230000035617 depilation Effects 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- 208000005171 Dysmenorrhea Diseases 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 7
- 208000019255 Menstrual disease Diseases 0.000 description 7
- 206010033799 Paralysis Diseases 0.000 description 7
- 208000025747 Rheumatic disease Diseases 0.000 description 7
- 230000004087 circulation Effects 0.000 description 7
- 210000004209 hair Anatomy 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 231100000862 numbness Toxicity 0.000 description 7
- 244000052769 pathogen Species 0.000 description 7
- 230000000552 rheumatic effect Effects 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 210000003371 toe Anatomy 0.000 description 7
- 206010062575 Muscle contracture Diseases 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- 206010040880 Skin irritation Diseases 0.000 description 6
- 230000003213 activating effect Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000001684 chronic effect Effects 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 208000006111 contracture Diseases 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 230000034994 death Effects 0.000 description 6
- 230000006735 deficit Effects 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 210000003127 knee Anatomy 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 230000002980 postoperative effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000036556 skin irritation Effects 0.000 description 6
- 231100000475 skin irritation Toxicity 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 210000002435 tendon Anatomy 0.000 description 6
- 210000001835 viscera Anatomy 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 206010027514 Metrorrhagia Diseases 0.000 description 5
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 5
- 238000001467 acupuncture Methods 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000007850 degeneration Effects 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 230000003118 histopathologic effect Effects 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 206010040872 skin infection Diseases 0.000 description 5
- 230000001629 suppression Effects 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 208000000616 Hemoptysis Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 230000002951 depilatory effect Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 229960001340 histamine Drugs 0.000 description 4
- 230000003447 ipsilateral effect Effects 0.000 description 4
- 210000000629 knee joint Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000004089 microcirculation Effects 0.000 description 4
- 230000001537 neural effect Effects 0.000 description 4
- 230000008058 pain sensation Effects 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000003389 potentiating effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000017423 tissue regeneration Effects 0.000 description 4
- 231100000041 toxicology testing Toxicity 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 3
- 206010063659 Aversion Diseases 0.000 description 3
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 3
- 206010020565 Hyperaemia Diseases 0.000 description 3
- 206010061245 Internal injury Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010037779 Radiculopathy Diseases 0.000 description 3
- 206010039491 Sarcoma Diseases 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 206010043376 Tetanus Diseases 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 230000002052 anaphylactic effect Effects 0.000 description 3
- 210000001185 bone marrow Anatomy 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 210000003164 cauda equina Anatomy 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 229960002986 dinoprostone Drugs 0.000 description 3
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 210000003754 fetus Anatomy 0.000 description 3
- 230000005021 gait Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 201000005404 rubella Diseases 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 210000000278 spinal cord Anatomy 0.000 description 3
- 230000008093 supporting effect Effects 0.000 description 3
- 206010042772 syncope Diseases 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 210000000689 upper leg Anatomy 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000255791 Bombyx Species 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 241000123586 Dipsacaceae Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 206010018691 Granuloma Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010024453 Ligament sprain Diseases 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 208000005141 Otitis Diseases 0.000 description 2
- 206010033425 Pain in extremity Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000008765 Sciatica Diseases 0.000 description 2
- 241000239226 Scorpiones Species 0.000 description 2
- 208000010040 Sprains and Strains Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000001217 buttock Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- VRSRXLJTYQVOHC-YEJXKQKISA-N corydaline Chemical compound C=1([C@H]2[C@H]3C)C=C(OC)C(OC)=CC=1CCN2CC1=C3C=CC(OC)=C1OC VRSRXLJTYQVOHC-YEJXKQKISA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000005786 degenerative changes Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 208000024756 faint Diseases 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 210000002850 nasal mucosa Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 229940100691 oral capsule Drugs 0.000 description 2
- 229940126701 oral medication Drugs 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 206010034754 petechiae Diseases 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 210000003497 sciatic nerve Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052979 sodium sulfide Inorganic materials 0.000 description 2
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 1
- 206010002027 Amyotrophy Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000180579 Arca Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000887125 Chaptalia nutans Species 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- VRSRXLJTYQVOHC-UHFFFAOYSA-N Corydaline Natural products CC1C2C=3C=C(OC)C(OC)=CC=3CCN2CC2=C1C=CC(OC)=C2OC VRSRXLJTYQVOHC-UHFFFAOYSA-N 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 208000003899 Foreign-Body Granuloma Diseases 0.000 description 1
- 208000005422 Foreign-Body reaction Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 241000142952 Hamamelidaceae Species 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010022562 Intermittent claudication Diseases 0.000 description 1
- 206010061246 Intervertebral disc degeneration Diseases 0.000 description 1
- 206010050296 Intervertebral disc protrusion Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 206010051326 Ligament calcification Diseases 0.000 description 1
- 241000893545 Liquidambar formosana Species 0.000 description 1
- QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 206010031009 Oral pain Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 240000009022 Smilax rotundifolia Species 0.000 description 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000003217 Tetany Diseases 0.000 description 1
- 102000002262 Thromboplastin Human genes 0.000 description 1
- 108010000499 Thromboplastin Proteins 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- PCWZKQSKUXXDDJ-UHFFFAOYSA-N Xanthotoxin Natural products COCc1c2OC(=O)C=Cc2cc3ccoc13 PCWZKQSKUXXDDJ-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 229960002045 bergapten Drugs 0.000 description 1
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 125000006268 biphenyl-3-yl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C1=C([H])C(*)=C([H])C([H])=C1[H] 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 208000018180 degenerative disc disease Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000013551 empirical research Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 210000001255 hallux Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 210000003035 hyaline cartilage Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000021156 intermittent vascular claudication Diseases 0.000 description 1
- 208000021600 intervertebral disc degenerative disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940029329 intrinsic factor Drugs 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000002078 massotherapy Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 229960004469 methoxsalen Drugs 0.000 description 1
- SQBBOVROCFXYBN-UHFFFAOYSA-N methoxypsoralen Natural products C1=C2OC(=O)C(OC)=CC2=CC2=C1OC=C2 SQBBOVROCFXYBN-UHFFFAOYSA-N 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 238000009608 myelography Methods 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229940011964 pentobarbital sodium 30 mg Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 230000010181 polygamy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000011555 rabbit model Methods 0.000 description 1
- 206010061928 radiculitis Diseases 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000036301 sexual development Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 210000001032 spinal nerve Anatomy 0.000 description 1
- 210000000273 spinal nerve root Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 210000002517 zygapophyseal joint Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
对照组 | 3.0±1.5 | 5.0±1.6 | 5.6±2.0 | |
本发明丸剂小剂量 | 1 | 1.0±0.6 | 3.5±1.6 | 4.4±1.4 |
本发明丸剂中剂量 | 2 | 0.7±0.5 | 1.4±0.9 | 1.2±0.96 |
本发明丸剂大剂量 | 4 | 0.5±0.2 | 1.2±1.12 | 0.4±0.7 |
腰痛宁组 | 4 | 1.1±0.32 | 2.0±0.23 | 2.6±1.4 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210299423.9A CN102872286B (zh) | 2012-08-21 | 2012-08-21 | 一种治疗腰间盘突出的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210299423.9A CN102872286B (zh) | 2012-08-21 | 2012-08-21 | 一种治疗腰间盘突出的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102872286A true CN102872286A (zh) | 2013-01-16 |
CN102872286B CN102872286B (zh) | 2014-06-18 |
Family
ID=47473956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210299423.9A Active CN102872286B (zh) | 2012-08-21 | 2012-08-21 | 一种治疗腰间盘突出的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102872286B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104107296A (zh) * | 2014-07-22 | 2014-10-22 | 房庆国 | 一种治疗月子病、腰椎间盘突出及风湿性腰腿痛的药物及其制备方法 |
CN104208347A (zh) * | 2014-07-31 | 2014-12-17 | 陈伟芳 | 一种治疗腰椎间盘突出症的药物及其制备方法 |
CN104398962A (zh) * | 2014-11-27 | 2015-03-11 | 青岛申达高新技术开发有限公司 | 一种治疗脾肾两虚型腰肌劳损的中药组合物及其制备方法 |
CN106822590A (zh) * | 2017-02-14 | 2017-06-13 | 四川双鑫生物科技有限公司 | 一种治疗腰间盘突出的软膏状药物及其制备方法 |
CN111529667A (zh) * | 2020-06-11 | 2020-08-14 | 浙江一真堂健康管理有限公司 | 一种用于治疗腰椎间盘突出症的中药组合物及应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101444611A (zh) * | 2007-11-26 | 2009-06-03 | 佛山德众药业有限公司 | 治疗腰腿痛、腰椎间盘突出症的中药组合物及其制备方法 |
CN102119989A (zh) * | 2011-03-08 | 2011-07-13 | 孙玉芝 | 一种治疗腰间盘突出、骨质增生、肩周炎、关节炎、颈椎病的中药胶囊 |
CN102258694A (zh) * | 2010-05-26 | 2011-11-30 | 李敬纯 | 一种治疗骨质增生、腰间盘突出的中药制剂及其制备方法 |
CN102397523A (zh) * | 2011-11-28 | 2012-04-04 | 吕会辰 | 一种治疗风湿、类风湿性关节炎和颈肩腰腿疼的药物 |
-
2012
- 2012-08-21 CN CN201210299423.9A patent/CN102872286B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101444611A (zh) * | 2007-11-26 | 2009-06-03 | 佛山德众药业有限公司 | 治疗腰腿痛、腰椎间盘突出症的中药组合物及其制备方法 |
CN102258694A (zh) * | 2010-05-26 | 2011-11-30 | 李敬纯 | 一种治疗骨质增生、腰间盘突出的中药制剂及其制备方法 |
CN102119989A (zh) * | 2011-03-08 | 2011-07-13 | 孙玉芝 | 一种治疗腰间盘突出、骨质增生、肩周炎、关节炎、颈椎病的中药胶囊 |
CN102397523A (zh) * | 2011-11-28 | 2012-04-04 | 吕会辰 | 一种治疗风湿、类风湿性关节炎和颈肩腰腿疼的药物 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104107296A (zh) * | 2014-07-22 | 2014-10-22 | 房庆国 | 一种治疗月子病、腰椎间盘突出及风湿性腰腿痛的药物及其制备方法 |
CN104208347A (zh) * | 2014-07-31 | 2014-12-17 | 陈伟芳 | 一种治疗腰椎间盘突出症的药物及其制备方法 |
CN104398962A (zh) * | 2014-11-27 | 2015-03-11 | 青岛申达高新技术开发有限公司 | 一种治疗脾肾两虚型腰肌劳损的中药组合物及其制备方法 |
CN106822590A (zh) * | 2017-02-14 | 2017-06-13 | 四川双鑫生物科技有限公司 | 一种治疗腰间盘突出的软膏状药物及其制备方法 |
CN111529667A (zh) * | 2020-06-11 | 2020-08-14 | 浙江一真堂健康管理有限公司 | 一种用于治疗腰椎间盘突出症的中药组合物及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102872286B (zh) | 2014-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101579416B (zh) | 一种骨科用膏药 | |
CN103520654B (zh) | 一种用于治疗膝骨关节炎的中药组合物及其制备方法 | |
CN102091258B (zh) | 一种祛除疤痕的中药组合物及其制备方法 | |
CN103860667B (zh) | 一种治疗腰肌劳损的中药组合物及其制备方法 | |
CN101810685B (zh) | 一种治疗膝关节炎症的中药组合物及其制备方法 | |
CN102847063B (zh) | 一种治疗气血两虚血瘀型糖尿病足的中药组合物及其制备方法 | |
CN101347536B (zh) | 治疗跌打损伤的外用制剂 | |
CN103751310A (zh) | 一种治疗筋膜炎的中药外用制剂及其制备方法 | |
CN104306495B (zh) | 一种治疗肩周炎的中药外用制剂及其制备方法 | |
CN103751633A (zh) | 一种治疗下肢静脉曲张的中药组合物及其制备方法 | |
CN102872286B (zh) | 一种治疗腰间盘突出的中药组合物及其制备方法 | |
CN104666698A (zh) | 一种治疗膝关节滑膜炎的中药外用膏剂及其制备方法 | |
CN104666579A (zh) | 一种治疗膝关节滑膜炎的中药组合物及其制备方法 | |
CN103705751A (zh) | 用于治疗风湿腰痛的中药组合物及其制备方法 | |
CN102526406B (zh) | 一种治疗神经根型颈椎病的中药贴膏及其制备方法 | |
CN102772712B (zh) | 一种治疗热毒炽盛血瘀型糖尿病足的中药组合物 | |
CN104435169A (zh) | 一种治疗骨伤骨折的中药组合物及其制备方法 | |
CN102861287A (zh) | 一种治疗湿热下注淤血型糖尿病足的中药组合物及其制备方法 | |
CN102000164A (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
CN103520655A (zh) | 一种治疗寻常型银屑病的中药组合物及其制备方法 | |
CN103768531B (zh) | 用于治疗类风湿关节炎的中药组合物及其制备方法 | |
CN104398962A (zh) | 一种治疗脾肾两虚型腰肌劳损的中药组合物及其制备方法 | |
CN104474114A (zh) | 一种治疗肾阳虚型腰肌劳损的中药组合物及其制备方法 | |
CN102178781A (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
CN103860676B (zh) | 一种治疗腰肌劳损的中药外用制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: QINGDAO HUAREN TECHNOLOGY INCUBATOR CO., LTD. Free format text: FORMER OWNER: YANG GAOLIN Effective date: 20140521 |
|
C14 | Grant of patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Xiqiang Inventor after: Sun Renguang Inventor after: Ma Xicai Inventor after: Wu Aifeng Inventor before: Sun Xianghong |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 266033 QINGDAO, SHANDONG PROVINCE TO: 266071 QINGDAO, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: SUN XIANGHONG TO: WANG XIQIANG SUN RENGUANG MA XICAI WU AIFENG |
|
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140521 Address after: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Applicant after: Qingdao Huaren Technology Incubator Co., Ltd. Address before: 266033 No. 138, Liu Liu Road, Sifang District, Shandong, Qingdao Applicant before: Yang Gaolin |
|
TR01 | Transfer of patent right |
Effective date of registration: 20171023 Address after: 401120, 5-, Yubei District, Chongqing, 1 Dragon Street 498 Patentee after: Chongqing Kai Tuo development in science and technology company limited Address before: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Patentee before: Qingdao Huaren Technology Incubator Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200709 Address after: 1121-144, 11 / F, 18 Zhongguancun Street, Haidian District, Beijing Patentee after: Beijing zhongmi Institute of traditional Chinese Medicine Address before: 401120 Jiale Ziguang Building 5-Business, 498 Hongjin Avenue, Longxi Street, Yubei District, Chongqing Patentee before: CHONGQING KAITUO TECHNOLOGY DEVELOPMENT Co.,Ltd. |